Catalyst Pharmaceuticals' Firdapse delivers strong growth with a 37% CAGR. Click here to find out why CPRX stock is a Hold.

Multiple system atrophy (MSA) is not exactly a household word – a situation that Alterity Therapeutics is seeking to change.

New York, New York-- (Newsfile Corp. - March 3, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...

Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of ...

Selarsdi (ustekinumab-aekn; Teva and Alvotech), and Yesintek (ustekinumab-kfce; Biocon Biologics), all biosimilars to Stelara (ustekinumab; Johnson & Johnson) are now available in the US.

Otulfi, an ustekinumab biosimilar for the reference product Stelara (ustekinumab), developed by Formycon AG, is now available ...

Global Nanotechnology Drug Delivery Market is valued at USD 85.5 Billion in 2022. Global Nanotechnology Drug Delivery Market valuation to reach USD 167.47 Billion by 2030. Nanotechnology Drug Delivery ...

The Europe Antibiotics Market is witnessing steady growth, driven by the increasing prevalence of infectious diseases, an aging population, and advancements in diagnostic capabilities. These factors ...

According to my Fitbit I walked over 110 miles in 8 days with these bad boys on,” wrote a reviewer of one pair on our list.